Practice Issue: Improving Patient Compliance

The MPhA Learning Portfolio

PROFESSIONAL DEVELOPMENT LOG

Name: J. Lerner License #: 12345 Year: 2005-2006

These are Date Program Title, Provider, Contact Hours specific File No. (accredited) or examples ACCR Non- Practice Issue (non- of: ( ACCR accredited) C Key Ideas/ E Thoughts/Learning U Points ’ s ) An Nov. Adherence to Asthma Therapy 1.0 Discussed preferred devices accredited 21/05 Provider: Novopharm for treatment in children (MDI program CCCEP # 060-1103 + spacer + facemask) and compared different devices and proper techniques A program Jan Treatment of Depression with New 1.75 0.75 Sertraline use vs. Fluoxetine that was 15/06 Antidepressants Article and other “new” accredited Provider: Organon antidepressants. Discussed for 1.75 CCCEP # 108-0304 side effect profiles and gave CEUs, but cases when combination use took 2.5 were beneficial. hours to complete Jan Pharmacist’s Letter 1.0 Antibiotics: rifampin, penicillin, 30/06 January 2006, Vol. 22 no. 1 tetracyclines etc. Combining ACPE # 123-456 AB’s and new treatment methods. A non- Feb Discussion with colleague, Dr. Sugar 2.0 Discussed preferred accredited 12/06 about brittle Type II Diabetics and combination therapy for learning patients with compliance issues. various patients we’ve both activity: encountered –what worked Discussion Practice Issue: Improving patient and what didn’t. Shared compliance articles about increasing compliance with patients. Feb Apotex CE Essentials Online: Stroke 2.0 Refresher on different types of 20/06 CCCEP # 383-0206 strokes, and the various treatment methods. Stroke prevention was also discussed. How to Mar 2/06 Diabetes and Heart Health Clinic 6.0 Review of current guidelines record Provider: Health Science Centre, for testing and treatment. BP Learning Refer to presented by Dr. J. Smith, Dr. R. testing, and screening for Projects in Learning Jones and K. Lee. blood sugars. PDL, if Project 1 applicable Practice Issue: To develop guidelines for the effective management of Type II Diabetes specific to my practice. Mar Video: Advancing Quality in the Name 6.0 Discussed different methods of 10/06 of Patient Safety preventing medication errors MPhA File # 23340M and best practice approach for informing patients & physicians and responding to the errors. April The Pharmacists Role in Helping 2.0 Discussed guidelines to help 30/06 Patients Achieve their Asthma Goals: patient gauge if their asthma is Is Total Control Achievable? well controlled. Provider: R- Briefcase Inhaled corticosteroids are CCCEP # 263-0405 mainstay in asthma therapy. A non- May Medical Letters on Drugs and 1.0 Treatment of menopausal accredited 14/06 Therapeutics. Vol. 3, No. 5, 2006. vasomotor symptoms. learning Drugs for percutaneous activity: Practice Issue: Drug knowledge coronary interventions – Reading anticoagulation therapy is an article recommended for all PCIs. July 5/06 Optimizing Pharmacy Care for 3.5 Schizophrenia: New dosing Individuals Living with Mental Illness efficiency, side effects and Provider: MPhA controversies surrounding MPhA File # 23065M various treatments. Bipolar Disorder: medication updates The MPhA Learning Portfolio

July Counselling Pediatric Patients 1.0 Dosage form and taste can 26/06 Provider: Novopharm CE Compliance play a significant role in Centre compliance. Discussed CCCEP # 151-0804 different factors that can attribute to non-compliance and how to improve compliance. August CPHA Professional Advancement 3.0 Guidelines for treatment of 19/06 Online Learning Centre: Children’s bacterial meningitis, chicken Health: Respolving Pediatric infections. pox and otitus media. CCCEP # 906-1202 Treatment options include: rifampin for prophylaxis bacterial meningitis tx (vs. cipro) An Sept Apotex CE Essentials Online: Angina 1.5 Guidelines for angina accredited 30/06 CCCEP #: 205-3352 treatment. Review of disease program POST-TEST NOT DONE states, various forms of but, angina and prevention because strategies. the post- test was not done, it is entered as a non- accredited learning activity How to Oct Preceptorship - Third Year Pharmacy 1.5 If glycemic targets are not record 10/06 Student achieved using lifestyle preceptor- MPhA File No. 25076M management within 2 to 3 ship as an Review of Canadian Diabetes months, antihyperglycemic accredited Association Clinical Practice Guidelines agents should be initiated. In learning for the management of Type II diabetes the presence of marked activity. (http://www.diabetes.ca/cpg2003/chapt hyperglycemia (A1C ≥9.0%), ers.aspx) antihyperglycemic agents should be initiated concomitant with lifestyle counselling. Further recommendations included regarding oral antihyperglycemic agents, insulin and combination therapies. TOTAL CONTACT HOURS 22.75 11.25 (minimum of 25 hours of learning activities each PD Year including a minimum of 15 CEUs) (PD Year is November 1st to October 31st)